These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33914142)

  • 41. Editorial for "Automatic Segmentation and Quantification of Nigrosome-1 Neuromelanin and Iron in MRI: A Candidate Biomarker for Parkinson's Disease".
    Reyes SC; Shahraki T; Soman S
    J Magn Reson Imaging; 2024 Aug; 60(2):548-549. PubMed ID: 37915261
    [No Abstract]   [Full Text] [Related]  

  • 42. Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.
    Wang J; Li Y; Huang Z; Wan W; Zhang Y; Wang C; Cheng X; Ye F; Liu K; Fei G; Zeng M; Jin L
    Eur J Neurol; 2018 Jul; 25(7):949-e73. PubMed ID: 29520900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imaging the Substantia Nigra in Parkinson Disease and Other Parkinsonian Syndromes.
    Bae YJ; Kim JM; Sohn CH; Choi JH; Choi BS; Song YS; Nam Y; Cho SJ; Jeon B; Kim JH
    Radiology; 2021 Aug; 300(2):260-278. PubMed ID: 34100679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Substantia nigra locations of iron-content, free-water and mean diffusivity abnormalities in moderate stage Parkinson's disease.
    Arribarat G; Pasternak O; De Barros A; Galitzky M; Rascol O; Péran P
    Parkinsonism Relat Disord; 2019 Aug; 65():146-152. PubMed ID: 31182373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
    Schwarz ST; Rittman T; Gontu V; Morgan PS; Bajaj N; Auer DP
    Mov Disord; 2011 Aug; 26(9):1633-8. PubMed ID: 21491489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nigrosome 1 imaging: technical considerations and clinical applications.
    Kim EY; Sung YH; Lee J
    Br J Radiol; 2019 Sep; 92(1101):20180842. PubMed ID: 31067082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Automated assessment of the substantia nigra on susceptibility map-weighted imaging using deep convolutional neural networks for diagnosis of Idiopathic Parkinson's disease.
    Shin DH; Heo H; Song S; Shin NY; Nam Y; Yoo SW; Kim JS; Yoon JH; Lee SH; Sung YH; Kim EY
    Parkinsonism Relat Disord; 2021 Apr; 85():84-90. PubMed ID: 33761389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parkinson's disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta.
    Langley J; Huddleston DE; Sedlacik J; Boelmans K; Hu XP
    Mov Disord; 2017 Mar; 32(3):441-449. PubMed ID: 28004859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative Susceptibility Mapping in Parkinson's Disease.
    Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
    PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.
    Du G; Lewis MM; Styner M; Shaffer ML; Sen S; Yang QX; Huang X
    Mov Disord; 2011 Aug; 26(9):1627-32. PubMed ID: 21618607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Signal Alteration of Substantia Nigra on 3.0T Susceptibility-weighted Imaging in Parkinson's Disease and Vascular Parkinsonism.
    Zhao XJ; Niu XY; You HY; Zhou M; Ji XB; Liu Y; Wu L; Ding XL
    Curr Med Sci; 2019 Oct; 39(5):831-835. PubMed ID: 31612404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism.
    Reiter E; Mueller C; Pinter B; Krismer F; Scherfler C; Esterhammer R; Kremser C; Schocke M; Wenning GK; Poewe W; Seppi K
    Mov Disord; 2015 Jul; 30(8):1068-76. PubMed ID: 25773707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential involvement of nigral subregions in idiopathic parkinson's disease.
    Sung YH; Lee J; Nam Y; Shin HG; Noh Y; Shin DH; Kim EY
    Hum Brain Mapp; 2018 Jan; 39(1):542-553. PubMed ID: 29064601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
    Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
    Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microvessels may Confound the "Swallow Tail Sign" in Normal Aged Midbrains: A Postmortem 7 T SW-MRI Study.
    Kau T; Hametner S; Endmayr V; Deistung A; Prihoda M; Haimburger E; Menard C; Haider T; Höftberger R; Robinson S; Reichenbach JR; Lassmann H; Traxler H; Trattnig S; Grabner G
    J Neuroimaging; 2019 Jan; 29(1):65-69. PubMed ID: 30407679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Iron Imaging as a Diagnostic Tool for Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Pyatigorskaya N; Sanz-Morère CB; Gaurav R; Biondetti E; Valabregue R; Santin M; Yahia-Cherif L; Lehéricy S
    Front Neurol; 2020; 11():366. PubMed ID: 32547468
    [No Abstract]   [Full Text] [Related]  

  • 57. Simple quantitative planimetric measurement of nigrosome-1 for clinical settings.
    Chau MT; Agzarian M; Wilcox RA; Dwyer A; Bezak E; Todd G
    J Neurol Sci; 2023 Nov; 454():120857. PubMed ID: 37939625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease.
    Lotfipour AK; Wharton S; Schwarz ST; Gontu V; Schäfer A; Peters AM; Bowtell RW; Auer DP; Gowland PA; Bajaj NP
    J Magn Reson Imaging; 2012 Jan; 35(1):48-55. PubMed ID: 21987471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of regional iron on the motor impairments of Parkinson's disease: A quantitative susceptibility mapping study.
    Guan X; Xuan M; Gu Q; Xu X; Huang P; Wang N; Shen Z; Xu J; Luo W; Zhang M
    J Magn Reson Imaging; 2017 May; 45(5):1335-1342. PubMed ID: 27545971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging.
    Hutchinson M; Raff U
    AJNR Am J Neuroradiol; 2000 Apr; 21(4):697-701. PubMed ID: 10782780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.